|
Teva Asthma Drug Would Infringe Mylan Patent, Judge Says
Law360 (subscription) Law360, New York (July 17, 2013, 7:18 PM ET) — A West Virginia federal judge ruled Wednesday that an asthma treatment proposed by generic drugmaker Teva Pharmaceutical USA Inc. would violate a patent covering Mylan Inc.'s Perforomist treatment. |
View full post on asthma – Google News